Hostname: page-component-848d4c4894-xfwgj Total loading time: 0 Render date: 2024-07-01T03:23:23.913Z Has data issue: false hasContentIssue false

MRI in Vitamin B12 Deficiency Myelopathy

Published online by Cambridge University Press:  05 August 2019

Eduardo R. Locatelli*
Affiliation:
Department of Neurology, Washington, DC Washington Hospital Center, the Department of Neurology, Washington, DC
Robert Laureno
Affiliation:
Department of Neurology, Washington, DC Washington Hospital Center, the Department of Neurology, Washington, DC
Pamela Ballard
Affiliation:
The George Washington University, and the National Rehabilitation Hospital, Washington, DC
Alexander S. Mark
Affiliation:
Department of Radiology, Washington, DC
*
Department of Neurology, The George Washington University Medical Center, 2150 Pennsylvania Avenue, #7-404, Washington, DC 20037, U.S.A.
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Little is known about vitamin B12 deficiency myelopathy's magnetic resonance imaging (MRI) manifestations and their relationship to the onset, evolution, and resolution of neurologic signs and symptoms.

Methods:

We present a case and review eleven additional reported cases of subacute combined degeneration of the spinal cord detected by MRI.

Results:

Our patient had increased T2-weighted signal and gadolinium contrast enhancement of the posterior columns in the cervical and thoracic regions and enhancement of the lateral columns in the high cervical region. This is a case with imaging evidence for lateral column lesions. Two prior reports have shown posterior column enhancement. T1-weighted images may show decreased signal in the posterior columns and sometimes demonstrate reversible spinal cord swelling. MRI abnormalities typically improve after vitamin replacement therapy. However, clinical signs may persist despite resolution of imaging abnormalities, and these abnormalities do not always resolve completely. In addition, symptoms may precede the imaging abnormality.

Conclusions:

Vitamin B12 deficiency may produce an increased T2-weighted signal, decreased T1-weighted signal, and contrast enhancement of the posterior and lateral columns of the spinal cord, mainly of the cervical and upper thoracic segments. Because the symptoms may precede any imaging abnormality, it is clear that spinal cord MRI may not be a highly sensitive, early test for subacute combined degeneration.

Résumé:

Résumé:<span class='italic'>Introduction:</span>

On connaît peu de choses sur les manifestations de la déficience en vitamine B12 à l'imagerie par résonance magnétique (RMN) et sur leur relation avec le début, l'évolution et la résolution des signes et des symptômes neurologiques.

<span class='italic'>Méthodes:</span>

Nous présentons un cas de dégénérescence combinée subaiguë de la moelle détecté par RMN et nous revoyons onze autres cas rapportés dans la littérature.

<span class='italic'>Résultats:</span>

Notre patient avait une augmentation du signal T2 à l'examen en séquence pondérée en T2 et une densification par le gadolinium au niveau de la corne latérale de la moelle à la région cervicale haute. Ceci constitue un cas avec observation à la RMN de lésions de la corne latérale. Chez deux autres cas, on rapportait un rehaussement de la corne postérieure de la moelle. Les images pondérées en T1 peuvent montrer un signal diminué dans les cornes postérieures et parfois un gonflement réversible de la moelle épinière. Il est typique de voir les anomalies de la RMN s'améliorer suite au traitement de remplacement vitaminique. Cependant, les signes cliniques peuvent persister en dépit de la résolution des anomalies observées à l'imagerie et ces anomalies ne disparaissent pas toujours complètement. De plus, les symptômes peuvent précéder les anomalies observées à l'imagerie.

<span class='italic'>Conclusions:</span>

La déficience en vitamine B12 peut produire une augmentation du signal pondéré en T2, une diminution du signal pondéré en T1 et un rehaussement du contraste des cornes postérieures et latérales de la moelle, surtout au niveau des segments cervicaux et thoracique supérieurs. Comme les symptômes peuvent précéder les anomalies observées à l'imagerie, il est clair que la RMN de la moelle n'est probablement pas un test hautement sensible pour détecter précocement la dégénérescence combinée subaiguë.

Type
Original Articles
Copyright
Copyright © The Canadian Journal of Neurological 1999

References

1. Tracey, JP, Schiffman, FJ. Magnetic resonance imaging in cobalamin deficiency [letter]. Lancet 1992; 339: 11721173.10.1016/0140-6736(92)90773-VGoogle Scholar
2. Timms, SR, Cure, JK, Kurent, JE. Subacute combined degeneration of the spinal cord: MR findings. Am J Neuroradiol 1993; 14: 12241227.Google Scholar
3. Murata, S, Naritomi, H, Sawada, T. MRI in subacute combined degeneration. Neuroradiology 1994; 36: 408409.10.1007/BF00612130Google Scholar
4. Tajima, Y, Mito, Y, Owada, Y, et al. MRI appearance of subacute combined degeneration of the spinal cord. Jpn J Psychiatry Neurol 1994; 48: 611614.Google Scholar
5. Wolansky, LJ, Goldstein, G, Gozo, A, et al. Subacute combined degeneration of the spinal cord: MRI detection of preferential involvement of the posterior columns in a child. Pediatr Radiol 1995; 25: 140141.10.1007/BF02010329Google Scholar
6. Duprez, TP, Gille, M, Vande Berg, BC, et al. MRI of the spine in cobalamin deficiency: the value of examining both spinal cord and bone marrow. Neuroradiol 1996; 38: 511515.10.1007/BF00626083Google Scholar
7. Larner, AJ, Zeman, AZ, Allen, CM, et al. MRI appearances in subacute combined degeneration of the spinal cord due to vitamin B12 deficiency. J Neurol Neurosurg Psychiatry 1997; 62: 99101.10.1136/jnnp.62.1.99Google Scholar
8. Küker, W, Hesselmann, V, Thron, A, et al. MRI demonstration of reversible impairment of the blood-CNS barrier function in subacute combined degeneration of the spinal cord. J Neurol Neuro surg Psychiatry 1997; 62: 298299.10.1136/jnnp.62.3.298Google Scholar
9. Ng, VW, Gross, M, Clifton, A. MRI appearances in vitamin B12 deficiency. Clin Radiol 1997; 52: 394396.10.1016/S0009-9260(97)80138-9Google Scholar
10. Imaiso, Y, Taniwaki, T, Yamada, T, et al. Myelopathy due to vitamin B12 deficiency, presenting only sensory disturbances in upper extremities: a case report. Rinsho Shinkeigaku 1997; 37: 135138.Google Scholar
11. Springer, SC, Key, JD. Vitamin B12 deficiency and subclinical infection with Giardia Lambia in an adolescent with agammaglobulinemia of Bruton. J Adolesc Health 1997; 20: 5861.10.1016/S1054-139X(96)00171-1Google Scholar
12. Berger, JR, Quencer, R. Reversible myelopathy with pernicious anemia: clinical/MR correlation. Neurology 1991; 41: 947948.Google Scholar
13. Haan, J, Haupts, M, Uhlenbrock, D. Magnetic resonance imaging (MRI), cranial computerized tomography (CCT), evoked potentials and cerebrospinal fluid (CSF) analysis in five patients with funicular myelosis. Neurosurg Rev 1987; 10: 209211.10.1007/BF01782049Google Scholar
14. Chatterjee, A, Yapundich, R, Palmer, CA, et al. Leukoencephalopathy associated with cobalamin deficiency. Neurology 1996; 46: 832834.10.1212/WNL.46.3.832Google Scholar
15. Stojsavljevic, N, Levic, Z, Drulovic, , et al. A 44-month clinical-brain MRI follow-up in a patient with B12 deficiency. Neurology 1997; 49: 878881.10.1212/WNL.49.3.878Google Scholar
16. Gero, B, Sze, G, Sharif, H. MR imaging of intradural inflammatory diseases of the spine. Am J Neuroradiol 1991; 12: 10091019.Google Scholar
17. Greenfield, JG, O’Flynn, E. Subacute combined degeneration and pernicious anemia. Lancet 1933; 2: 6263.10.1016/S0140-6736(00)78539-4Google Scholar
18. Clarke, JM. On spinal cord degeneration and anemia. Brain 1904; 27: 441459.10.1093/brain/27.4.441Google Scholar